Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial

Henricus J. Duckers1, MD, PhD; Jaco Houtgraaf1, MD; Christoph Hehrlein2, MD, PhD; Joachim Schofer3, MD, PhD; Johannes Waltenberger4, MD, PhD; Anthony Gershlick5, MD, PhD; Jozef Bartunek6, MD, PhD; Christoph Nienaber7, MD; Carlos Macaya8, MD, PhD; Nicholas Peters9, MD; Peter Smits10, MD, PhD; Thomasz Siminiak11, MD, PhD; Walter van Mieghem12, MD; Victor Legrand13, MD, PhD; Patrick W. Serruys1, MD, PhD